BioSpace News Archive

Biotech Beach

SkylineDx confirms positive results first independent validation skin cancer test

SkylineDx announced, during the European Society for Medical Oncology congress, that it successfully validated the performance of their skin cancer diagnostic test on the first, independent, European dataset.

October 1, 2019
·
2 min read
Drug Development

NOXXON Presents Latest Clinical Data From Phase 1/2 Nox-a12 / Keytruda® Combination Trial At The ESMO Congress

NOXXON Pharma N.V. announced the latest clinical results from the Phase 1/2 study of NOX-A12 in combination with Keytruda® in patients with microsatellite-stable, metastatic pancreatic and colorectal cancer in a poster presentation at the European Society for Medical Oncology Congress in Barcelona, Spain.

October 1, 2019
·
3 min read
Drug Development

PARP inhibitor plus chemotherapy improves progression-free survival for advanced ovarian cancer patients

Phase III trial validates the benefit of veliparib for patients without a BRCA mutation

October 1, 2019
·
4 min read
Drug Development

Evgen Pharma - ESMO presentation of Phase II STEM clinical data

Evgen Pharma plc announces that the clinical data from the completed open-label Phase II STEM trial was presented in poster format yesterday at the 2019 European Society of Medical Oncology Congress in Barcelona.

October 1, 2019
·
2 min read
Policy

Former Innate Immunotherapeutics Board Member Chris Collins Expected to Plead Guilty to Insider Trading

On Monday, the House Republican resigned his congressional seat ahead of the expected plea.

October 1, 2019
·
2 min read
·
Alex Keown
Policy

Some Opioid Drugmakers Could Use Purdue’s Bankruptcy As a Way to Avoid Litigation

Following Purdue Pharma’s Chapter 11 filing last month, other opioid makers are exploring ways to settle their own litigation problems by participating in the OxyContin drugmaker’s bankruptcy proceedings.

October 1, 2019
·
2 min read
·
Alex Keown
Business

Insilico and Janssen take another step towards predictive biomanufacturing: Digital Twins allow for accelerated timelines in cell line development for biologics production

Insilico Biotechnology AG and the Janssen Pharmaceutical Companies of Johnson & Johnson announced an agreement to apply Insilico’s predictive Digital Twins for the early selection of high-performing cells to further boost efficiency and throughput of their cell line development workflow.

October 1, 2019
·
3 min read
Business

Creoptix Closes Successful Series C Financing Round to Support Further Growth

Creoptix AG announced that is has raised CHF 8 million in the first closing as part of a Series C financing round.

October 1, 2019
·
3 min read
Deals

Novo Seeds co-leads €20 Million Series A Financing in STipe Therapeutics

Novo Seeds, the company creation team of Novo Holdings, announced that it has co-led the €20 million Series A financing round in STipe Therapeutics (STipe).

October 1, 2019
·
4 min read
Business

Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer Ingelheim

Less than one year after signing agreement, the GPCR expert has reached key discovery milestones in two independent projects

October 1, 2019
·
2 min read